4hmn
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
==Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorophenyl)piperazin-1-yl)(morpholino)methanone (24)== | ==Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorophenyl)piperazin-1-yl)(morpholino)methanone (24)== | ||
- | <StructureSection load='4hmn' size='340' side='right' caption='[[4hmn]], [[Resolution|resolution]] 2.40Å' scene=''> | + | <StructureSection load='4hmn' size='340' side='right'caption='[[4hmn]], [[Resolution|resolution]] 2.40Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4hmn]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4hmn]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4HMN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4HMN FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=16J:[4-(4-CHLOROPHENYL)PIPERAZIN-1-YL](MORPHOLIN-4-YL)METHANONE'>16J</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.4Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=16J:[4-(4-CHLOROPHENYL)PIPERAZIN-1-YL](MORPHOLIN-4-YL)METHANONE'>16J</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4hmn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4hmn OCA], [https://pdbe.org/4hmn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4hmn RCSB], [https://www.ebi.ac.uk/pdbsum/4hmn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4hmn ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/AK1C3_HUMAN AK1C3_HUMAN] Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 21: | Line 21: | ||
==See Also== | ==See Also== | ||
- | *[[Prostaglandin F synthase|Prostaglandin F synthase]] | + | *[[Prostaglandin F synthase 3D structures|Prostaglandin F synthase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Atwell | + | [[Category: Large Structures]] |
- | [[Category: Brooke | + | [[Category: Atwell GJ]] |
- | [[Category: Denny | + | [[Category: Brooke DG]] |
- | [[Category: Flanagan | + | [[Category: Denny WA]] |
- | [[Category: Heinrich | + | [[Category: Flanagan JU]] |
- | [[Category: Jamieson | + | [[Category: Heinrich DM]] |
- | [[Category: Owen | + | [[Category: Jamieson SMF]] |
- | [[Category: Raynham | + | [[Category: Owen PJ]] |
- | [[Category: Rigoreau | + | [[Category: Raynham T]] |
- | [[Category: Samlal | + | [[Category: Rigoreau LJM]] |
- | [[Category: Schroeder | + | [[Category: Samlal SS]] |
- | [[Category: Silva | + | [[Category: Schroeder E]] |
- | [[Category: Soudy | + | [[Category: Silva S]] |
- | [[Category: Trivier | + | [[Category: Soudy C]] |
- | [[Category: Turnbull | + | [[Category: Trivier E]] |
- | + | [[Category: Turnbull AP]] | |
- | + | ||
- | + | ||
- | + |
Current revision
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorophenyl)piperazin-1-yl)(morpholino)methanone (24)
|
Categories: Homo sapiens | Large Structures | Atwell GJ | Brooke DG | Denny WA | Flanagan JU | Heinrich DM | Jamieson SMF | Owen PJ | Raynham T | Rigoreau LJM | Samlal SS | Schroeder E | Silva S | Soudy C | Trivier E | Turnbull AP